Updates for 2020

FDLI remains committed to providing high-quality educational programs while keeping our members and event attendees safe during the current pandemic. With this in mind, we are excited to announce that the 2020 Enforcement, Litigation, and Compliance Conference will be a completely virtual event. Please know we are actively exploring options to ensure an engaging and enjoyable experience with ample opportunities to connect with your peers. Be sure to check the course website regularly for additional announcements and updates.

Why Attend?

Preliminary Agenda

The annual Enforcement, Litigation, and Compliance Conference brings together industry, regulators, attorneys, litigators, academics, and consultants to discuss trends and issues in enforcement and compliance, the latest developments in both civil and criminal litigation, and recent cases and settlements. This year’s conference will be an all-virtual event, offering an opportunity to hear from and interact with top officials from FDA, DOJ, FTC, and other government agencies. In this time of many unknowns, come hear from your peers about they are staying compliance and inspection ready, what companies need to do to plan for next year, trends in competitor litigation, and government priorities post-election.

Conference Highlights:

  • Hear about top issues, priorities, and goals for 2021 directly from ORA and FDA’s Center Compliance Directors
  • Gain practical tips and best practices on preparing for virtual inspections – and whether they are recommended
  • Learn about enforcement and litigation potential regarding the PREP Act and EUAs, and what happens post-emergency and enforcement discretion periods
  • Discuss the enforcement and compliance impacts on FDA in a post-COVID era
  • Explore trends in litigation in light of reduced government enforcement actions


Call for Proposals

FDLI and the Conference Planning Committee thanks those who participated in the Call for Proposals this summer. The input received from industry stakeholders helps us plan a timely program. If you submitted a proposal, you will be notified of the status of your proposal in September.

Register by December 8 and SAVE!


Industry & Firms

  • +$200 for non-members
  • +$100 after 12/8/20


  • +$100 for non-members
  • +$100 after 12/8/20


  • +$100 for non-members
  • +$100 after 12/8/20


  • +$100 for non-members
  • +$100 after 12/8/20


  • transcripts required
  • transcripts required
Register Now


Internet Explorer and Microsoft Edge are not supported by the checkout process.

Please use Chrome, Firefox, or Safari.  If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.

On-Demand Access Available to Registrants

As a registrant, you will receive access to the recorded live sessions of the conference through January 15. Use this access to revisit engaging sessions, or to catch the sessions you weren’t able to attend in real time.

You can transfer your registration to another person at your organization for no cost by notifying us of the change. If you notify FDLI in writing at least five business days prior to the meeting, you can cancel your registration for a full refund (less a $75 fee). Refunds will be applied against the original form of payment.  

Our event policies are listed here. If you should have any further questions, please contact us at [email protected] or 800-956-6293.


Sponsorship opportunities are available. Please let us know if you would like more information.

Premier Sponsor




Lanyard Sponsor




Gold Sponsor

Gold Sponsor




Gold Sponsor




Silver Sponsor

Silver Sponsor





Silver Sponsor




Silver Sponsor

Bronze Sponsor



Bronze Sponsor

Planning Committee


Sonali P. Gunawardhana, Shook, Hardy & Bacon LLP

Committee Members 

Hannah Bornstein, Nixon Peabody LLP
Adrienne Franco Busby, Faegre Drinker LLP
Maya P. Florence, Skadden, Arps, Slate, Meagher & Flom LLP
Stephanie Haggarty, Pfizer, Inc.
Daniel G. Jarcho, Alston & Bird LLP
Charles N. Jolly, Baker Donelson
Pete J. Leininger, King & Spalding LLP
Anne K. Miller, Medtronic
Sun “Sandra” Park, Genentech, Inc.
Bob A. Rhoades, Validant
Suzie Loonam Trigg, Haynes and Boone LLP
Anne K. Walsh, Hyman, Phelps & McNamara, PC
Beth P. Weinman, Ropes & Gray LLP
Fran Zipp, Lachman Consultants